Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Laura Riley

9PUBLICATIONS

23CO-AUTHORS

Gene and molecular therapyClinical pharmacology and therapeuticsCardiology (incl. cardiovascular diseases)Infectious diseasesIntensive care

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (9)

Sort by Publication Date:

|Apr 01, 2026

2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Antiviral Treatment for Mild to Moderate COVID-19 in Adults.

Amy Hirsch Shumaker, Adarsh Bhimraj, Roger Bedimo

|Apr 01, 2026

2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Baricitinib vs. Tocilizumab.

Nandita Nadig, Adarsh Bhimraj, Kelly Cawcutt

|Sep 09, 2025

2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Abatacept.

Nandita Nadig, Adarsh Bhimraj, Kelly Cawcutt

|Aug 20, 2025

2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Infliximab.

Nandita Nadig, Adarsh Bhimraj, Kelly Cawcutt

|Aug 04, 2025

2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Pemivibart for Pre-exposure Prophylaxis, Vilobelimab for Critical Illness, and Abatacept or Infliximab for Severe or Critical Illness.

Adarsh Bhimraj, Yngve Falck-Ytter, Lindsey R Baden

|May 22, 2025

2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Vilobelimab.

Nandita Nadig, Adarsh Bhimraj, Kelly Cawcutt

Pageof 2

Frequent Collaborators

6 joint publications

Shmuel Shoham

6 joint publications

Roger Bedimo

6 joint publications

Pablo Tebas

6 joint publications

Kathleen Chiotos

6 joint publications

Adarsh Bhimraj

4 joint publications

Kara W Chew

4 joint publications

Greg S Martin

4 joint publications

Eric S Daar

2 joint publications

David V Glidden

2 joint publications

Jonathan Z Li

Frequent Collaborators

6 joint publications

Shmuel Shoham

6 joint publications

Roger Bedimo

6 joint publications

Pablo Tebas

6 joint publications

Kathleen Chiotos

Top Related Videos

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on : Nov 05, 2021

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

Published on : Sep 15, 2023

COVID-19 Seroprevalence Test for IgG Antibody Levels Among Healthy Donors Across Different Pandemic Phases in Jeddah

COVID-19 Seroprevalence Test for IgG Antibody Levels Among Healthy Donors Across Different Pandemic Phases in Jeddah

Published on : Jun 24, 2025

See more related videos

Top Related Videos

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on : Nov 05, 2021

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

Published on : Sep 15, 2023

COVID-19 Seroprevalence Test for IgG Antibody Levels Among Healthy Donors Across Different Pandemic Phases in Jeddah

COVID-19 Seroprevalence Test for IgG Antibody Levels Among Healthy Donors Across Different Pandemic Phases in Jeddah

Published on : Jun 24, 2025

See more related videos